Document is current
Any future updates will be listed below
-
Authors
Basolo, Alessio https://orcid.org/0000-0001-6888-7080
Paolucci, Giordano
Piaggi, Paolo
Angeli, Valentina
Bechi Genzano, Susanna
Fierabracci, Paola
Vignali, Edda
Bologna, Chiara
Salvetti, Guido
Chiovato, Luca
Natali, Andrea
Krakoff, Jonathan
Landi, Alberto
Santini, Ferruccio
-
Funding
Funding for this research was provided by:
Italian Ministry of University and Research (202229ET3S)
European Union (Italian National Recovery and Resilience Plan (PNRR) Spoke 8, WP1, Spoke 6 - Precision Medicine \& Personalized Healthcare (CUP I53C22000780001))
- License Information
-
More Information
Article History
Received: 21 August 2025
Accepted: 23 September 2025
First Online: 8 October 2025
Declarations
:
: FS has run projects for and/or served as a consultant, board member, and/or speaker for Novonordisk. A.B. is member of the editorial board of the Journal of Endocrinological Investigation. A.B., G.P., V.A., S.B.G., P.F., C.B., G.S., F.S. have received travel funds from Novo Nordisk.
: The study was approved by the Regional Ethics Committee for Clinical Trials of the Tuscany, Region Section: AREA VASTA NORD OVEST (register number 19543). All patients gave their written and informed consent to participate. The procedures employed in the study are in accordance with the 1964 Helsinki Declaration and its later amendments.
